Navigation Links
Arena Pharmaceuticals' Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
Date:10/12/2009

SAN DIEGO, Oct. 12, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that lorcaserin will be featured in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC.

The line-up includes a late-breaking abstract oral presentation of results from BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management), a Phase 3 trial for which Arena reported positive, highly significant top-line results in September. Arena will also present new data analyses from lorcaserin's successful Phase 3 pivotal program in oral and poster sessions. In an independent clinical symposium, expert academic scientists and physicians will spotlight the 5HT-2C mechanism for weight management.

The positive results from our Phase 3 pivotal program highlight lorcaserin's potential to provide physicians with a treatment option that combines three important attributes - efficacy, safety and tolerability

"- critical to broad applicability in the majority of their patients to help manage weight and improve cardiometabolic health," stated William R. Shanahan, M.D., Arena's Vice President and Chief Medical Officer. "The breadth of presentations featuring lorcaserin at The Obesity Society's annual scientific meeting speaks to the strong interest physicians have in this drug candidate."

Obesity 2009: Presentation Schedule

    Saturday, October 24, 2009

        -- Pre-Conference Session: Pharmacotherapy Update
           Time: 1:00 - 3:45 p.m. Eastern Time (ET)
           Chairs: Ken Fujioka, M.D., Louis J. Aronne, M.D., and Richard
            Pratley, M.D.
           Presenter: Christen M. Anderson, M.D., Ph.D.

    Sunday, October 25, 2009

        -- Poster Session
           Time: on display 1:00 -
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014  The objective of this market ... labs and research facilities across North America ... This study carries out an assessment of the current ... diagnostic, and law enforcement forensics labs. It also provides ... hazards, PPE segments, and safety regulations specific to labs ...
(Date:9/23/2014)... Sept. 23, 2014   MedNet Solutions , a global ... is pleased to announce that it will once again be ... (SCDM) Annual Conference, to be held this year from September ... , Nevada. MedNet team members, in conjunction with representatives from many ... will also be in attendance, will be providing demonstrations of ...
(Date:9/23/2014)... 23, 2014 EnzymeBioSystems (OTCBB: ENZB) (OTCQB: ... the process of evaluating an enzyme compound which ... tumors. In an effort to evaluate this compound, management ... contract research organizations to enlist their expertise in ... of an antitumor natural product called amooranin.  Specifically, ...
Breaking Medicine Technology:Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 2Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 3MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2EnzymeBioSystems Announces Progress with an Enzyme Compound 2
(Date:9/23/2014)... and Academia Sinica, the preeminent academic institution in ... a collaborative agreement to develop a unique educational ... with opportunities to translate innovative technologies and commercially ... was signed Sept.12 in Taipei by Harris Lewin, ... President Chi-Huey Wong of Academia Sinica. The program ...
(Date:9/23/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on Jalapeno Bagels . ... Label Jalapeno Bagels are recalled as they may contain ... Jalapeno Bagels were sold in the self-service bins or ... into consideration the latest developments, AttorneyOne.com monitor daily and ...
(Date:9/23/2014)... Kathleen Doheny HealthDay Reporter ... at very low birth weights, breast milk is more likely ... infection known as cytomegalovirus (CMV), a new study finds. ... infants -- all of whom weighed 3.3 pounds or less ... of CMV infection, to see whether breast milk or transfusions ...
(Date:9/23/2014)... 23, 2014 (HealthDay News) -- Both drinking and getting ... for alcohol abuse by high school students, a new ... of high school students who drink, could help expand ... already drink, to stop them from becoming binge drinkers, ... age of first alcohol use and progression to first ...
(Date:9/23/2014)... DC (PRWEB) September 23, 2014 ... care? The National Quality Forum (NQF) released ... ( http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( http://bit.ly/1tX3lzA ... rising cost of healthcare, how patients define affordability, ... consumers to get the best possible healthcare at ...
Breaking Medicine News(10 mins):Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Publix Private Label Jalapeno Bagels Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Finding Affordable Care: Asking the Right Question is Key 2
... /PRNewswire-USNewwire/ - Governor Edward G.,Rendell tonight announced the ... behalf of all Pennsylvania, Midge and I extend ... we mourn the passing,of one of the strongest, ... and prayers are with Catherine,s family. She will ...
... distribution helps prevent malaria, ALEPE, Cote d,Ivoire, ... Church and their partners worldwide helped Cote d,Ivoire,s,National ... integrated health,campaign November 11 that will vaccinate 3.5 ... blanket the country with bed nets to,stop the ...
... 13 , - Diabetes Activists Worldwide Organize Events ... Diabetes in Children and Adolescents, November 14 is ... over 250,million people with diabetes worldwide. World Diabetes Day ... for action to improve care,prevent the disease in those ...
... often do better, study finds , , WEDNESDAY, Nov. 12 ... coronary angioplasty at community hospitals are more likely to ... than 83 such procedures a year, researchers report. , ... vessels and used to inflate a tiny balloon that ...
... Paper Outlines Plans to,Improve Healthcare Coverage While ... Value, WASHINGTON, Nov. 12 US ... cancer treatment and research networks,representing approximately 1,200 ... Baucus,s (D-MT) "Call to Action: Health,Reform 2009," ...
... 12 Consumer,Watchdog countered Senator Max Baucus, (D-MT) contention ... Americans by pointing to a,poll showing that voters overwhelmingly ... told they might have to pay some of the,premium ... support such a plan and nearly,two-thirds (63%) were opposed ...
Cached Medicine News:Health News:Governor Rendell Announces the Passing of Lt. Gov. Catherine Baker Knoll 2Health News:Governor Rendell Announces the Passing of Lt. Gov. Catherine Baker Knoll 3Health News:Governor Rendell Announces the Passing of Lt. Gov. Catherine Baker Knoll 4Health News:Photo: United Methodist Church, Partners Launch Life-Saving Campaign in Cote d'Ivoire 2Health News:Millions Mark World Diabetes Day 2Health News:Millions Mark World Diabetes Day 3Health News:Millions Mark World Diabetes Day 4Health News:With Angioplasty, More Is Better 2Health News:US Oncology Applauds Senator Baucus's Healthcare Reform 'Call to Action' for 2009, Supports Collaborative Measures to Enhance Cancer Patients' Access to Care While Improving Quality and Access 2
Economy Apron, Excellent Protection, Value Priced...
Pregnancy Apron...
All Day Comfort for the Lower Body...
Weight adjuster flexible back, comfortably places more weight on hips, less weight on shoulders....
Medicine Products: